Skip to content
BTFR banner - small

Tuesday, April 30, 2024, 4:00 PM 11:35 PM

Wednesday, May 01, 2024, 8:00 AM 11:36 PM

Add to Calendar

National Jewish Health 1400 Jackson St
Denver, Colorado 80206

Keynote Speakers

Doris Kearns Goodwin | Featured Speaker

Doris Goodwill Image V2Doris Kearns Goodwin is a world-renowned presidential historian, public speaker and Pulitzer Prize- winning, New York Times #1 best-selling author. Since 2020 she has served as executive producer for the History Channel’s miniseries events Washington, Abraham Lincoln, and Theodore Roosevelt, with more to come!

Her seventh book, "Leadership in Turbulent Times," was published in September 2018 to critical acclaim and became an instant New York Times bestseller. A culmination of Goodwin’s five-decade career of studying the American presidents focusing on Presidents Abraham Lincoln, Theodore Roosevelt, Franklin Roosevelt and Lyndon Baines Johnson, the book provides an accessible and essential road map for aspiring and established leaders in every field, and for all of us in our everyday lives.

Goodwin’s career as a presidential historian and author was inspired when as a 24-year-old graduate student at Harvard she was selected to join the White House Fellows, one of America’s most prestigious programs for leadership and public service. Goodwin worked with Johnson in the White House and later assisted him in the writing of his memoirs.

She then wrote "Lyndon Johnson and the American Dream," which became a national bestseller and achieved critical acclaim. It was re-released in 2019 with a new foreword highlighting LBJ’s accomplishments in domestic affairs that have stood the test of time.

Goodwin was awarded the Pulitzer Prize for "No Ordinary Time: Franklin and Eleanor Roosevelt: The Home Front in World War II." "The Fitzgeralds and the Kennedys" was adapted into an award-winning five-part television miniseries. Her memoir "Wait Till Next Year" is the heartwarming story of growing up loving her family and baseball. Her sixth book, "The Bully Pulpit: Theodore Roosevelt, William Howard Taft, and the Golden Age of Journalism," won the Carnegie Medal and is being developed into a film. Goodwin’s "Team of Rivals: The Political Genius of Abraham Lincoln" served as the basis for Steven Spielberg’s hit film Lincoln and was awarded the prestigious Lincoln Prize, the inaugural Book Prize for American History, and the Lincoln Leadership Prize.

Well known for her appearances and commentary on television, Goodwin is frequently seen in documentaries including Ken Burns’ The History of Baseball and The Roosevelts: An Intimate History; and on news and cable networks, and shows including Meet The Press and The Late Show with Stephen Colbert. She played herself as a teacher on The Simpsons and a historian on American Horror Story.

Goodwin graduated magna cum laude from Colby College. She earned a doctorate degree in Government from Harvard University, where she taught Government, including a course on the American Presidency. Among her many honors and awards, Goodwin was awarded the Charles Frankel Prize, the Sarah Josepha Hale Medal, the New England Book Award, as well as the Carl Sandburg Literary Award. Goodwin recently founded Pastimes Productions with Beth Laski to develop and produce film, television and digital projects.

Goodwin lives in Boston, Massachusetts. She was the first woman to enter the Boston Red Sox locker room in 1979, and is a devoted fan of the World Series-winning team.

Rob Allen

Rob Allen

President and Chief Executive Officer
Intermountain Health

Rob Allen is president and CEO of Utah-based Intermountain Health, the largest nonprofit health system in the Intermountain West. It is also the parent organization of Saint Joseph Hospital, the inpatient partner of National Jewish Health. Mr. Allen has served in executive leadership at Intermountain for 28 years, including 5 years as chief operating officer. He was named as one of the top 100 most influential people in healthcare for 2023 and previously as one of the top 25 COOs by Modern Healthcare.

In addition to his leadership roles at Intermountain, Mr. Allen held CEO positions at hospitals and health systems in Wyoming, New Jersey and Massachusetts. He earned his MBA from Utah State University and a BS in operations management from Brigham Young University. 

Mr. Allen has helped propel Intermountain Health to national recognition as a leading model for innovating health and wellness solutions, increasing value, and improving affordability and accessibility to all. He also led their nationally recognized operational work and continuous improvement culture to align providers, caregivers and services across much of the interior west. He has a passion for mentoring other healthcare executives. A fellow of the American College of Healthcare Executives, Rob has served on many foundation, chamber, and service boards.


Jandel Allen-Davis, MD

President and Chief Executive Officer
Craig Hospital

Dr. Jandel Allen-Davis leads Denver-based Craig Hospital, a world-renowned rehabilitation hospital that specializes exclusively in neurorehabilitation and research for patients with spinal cord injury and traumatic brain injuries. Previously, she was Vice President of Government, External Relations and Research for Kaiser Permanente Colorado.  

Dr. Allen-Davis is board certified in obstetrics and gynecology and was in active practice for 25 years. A graduate of Dartmouth College and Dartmouth Medical School, she completed her residency at Thomas Jefferson University Hospital in Philadelphia. 

She served on the National Jewish Health Board of Directors for 7 years and was a member of the Quality and Safety Committee. She currently serves on several other boards, including the Denver Metro Chamber of Commerce. Dr. Allen-Davis also serves as a C-Class Director of the Kansas City Federal Reserve Bank Board of Governors.

Among her many notable achievements is the Del Hock Lifetime Achievement Award from the Denver Metro Chamber of Commerce. The award recognized Dr. Allen-Davis for her wisdom, involvement and leadership within the community.

Greg P Downey

Gregory P. Downey, MD

Executive Vice President, Academic Affairs and Provost;
Drs. Harold and Mary Zirin Chair in Pulmonary Biology
National Jewish Health
Past President, American Thoracic Society

Dr. Greg Downey oversees academic and research programs at National Jewish Health, integrating the clinical and research efforts of the Departments of Medicine, Pediatrics and Immunology and Genomic Medicine. 

Previously, he was at the University of Toronto and held a Canada Research Chair in Respiration from the Canadian Institutes of Health Research. Dr. Downey received his MD from the University of Manitoba and completed his internship and residency at Beth Israel and Brigham and Women’s Hospital, Harvard Medical School. He completed both a clinical and research fellowship at National Jewish Health, the latter of which while simultaneously serving as a staff physician and medical director for our Adult Special Care Unit.  

Dr. Downey has authored more than 230 scientific publications, which have been cited more than 20,000 times. He has received numerous honors, including for outstanding contributions to cystic fibrosis research and for his work on Mechanisms of Epithelial Injury and Repair in Acute Lung Injury. He has served as associate editor of the American Journal of Respiratory Cell and Molecular Biology since 2002 and is currently past president of the American Thoracic Society. 

Gleen A. Hirsch

Glenn A. Hirsch, MD, MHS, FACC

Chief, Division of Cardiology
Medical Director, Cardiovascular Service Line 
National Jewish Health and Saint Joseph Hospital

Dr. Glenn Hirsch heads Cardiology for National Jewish Health and our partner Saint Joseph Hospital in Denver. Previously, he has held faculty positions at the University of Louisville and The Johns Hopkins University School of Medicine. 

Dr. Hirsch earned his medical degree at Loyola University Chicago Stritch School of Medicine. He completed his residency in internal medicine at the University of Michigan and a fellowship in cardiovascular medicine at The Johns Hopkins Hospital and at the National Heart, Lung and Blood Institute. He earned a master’s degree in cardiovascular epidemiology at The Johns Hopkins Bloomberg School of Public Health. 

Dr. Hirsch has led local, national and international educational projects, participated in numerous cardiovascular imaging research projects, and authored dozens of peer-reviewed publications. He has been instrumental in expanding cardiology at National Jewish Health by recruiting top physician-scientists in pulmonary hypertension; invasive and non-invasive cardiology; women’s health; and the emerging area of cardio-oncology.

William Janssen

William J. Janssen, MD

Section Head of Critical Care Medicine; Reilly Endowed Chair in Lung Injury and Repair, Interstitial Lung Disease; Assistant Vice President of Academic Affairs National Jewish Health

Dr. William Janssen leads the Section of Critical Care Medicine, our strategic priority of artificial intelligence and strategic planning for the translational research enterprise. 

Dr. Janssen received his medical degree from The Ohio State University, where he served as chief resident. He completed his fellowship in pulmonary and critical medicine at the University of Colorado. A leader in the field, he lectures nationally, and publishes in peer-reviewed journals and has been named one of the “Best Doctors in America” for 12 consecutive years. 

At the height of the COVID-19 pandemic, he mobilized clinical care teams from National Jewish Health to support hospitals nationwide, including Mount Sinai in New York and University of Southern California Keck Hospital, while overseeing critical care services for thousands of patients in Colorado. 

Dr. Janssen recently received a prestigious 7-year R35 program grant from the National Institutes of Health for his groundbreaking study of blood cells that filter particles to repair damaged lung tissue. The findings could improve treatment of disease, including chronic obstructive pulmonary disease, COVID-19, lung infection and pulmonary hypertension.


Donald Y.M. Leung, MD, PhD

Head, Division of Pediatric Allergy & Clinical Immunology; Distinguished Professor of Pediatrics;
Edelstein Family Chair in Pediatric Allergy-Immunology
National Jewish Health

Dr. Donald Y.M. Leung has led the Pediatric Allergy-Immunology division at National Jewish Health since 1989. He attended the University of Chicago where he earned his MD and a PhD in biochemistry. He has also served on the faculty of Harvard Medical School.

Dr. Leung’s research focus is atopic dermatitis (eczema). He was honored with the American Academy of Allergy, Asthma and Immunology (AAAAI) Distinguished Scientist Award for his seminal work in improving quality of life for those suffering from eczema. He also served as editor-in-chief for nearly 20 years of The Journal of Allergy and Clinical Immunology, the most highly cited journal in the field and was the recipient of the AAAAI Distinguished Service Award for these efforts. 

Dr. Leung has authored more than 800 scientific publications, has received 40+ federal research grants and numerous awards, including being named to lists of the World’s Most Highly Cited Authors in Immunology and America’s Top Doctors and recognized as a Legend in Allergy. Additionally, Dr. Leung developed a novel, minimally invasive skin taping technique to help us better understand and diagnose eczema, and has expanded this method to study skin reactions from immunotherapy cancer treatment and birth cohorts.

Max Seibold

Max A. Seibold, PhD

Wohlberg and Lambert Endowed Chair of Pharmacogenomics
Director of Regenerative Medicine and Genome Editing Program; Director of Computational Biology Program;
Co-Director of the Mucosal Inflammation Program
National Jewish Health

Dr. Seibold’s leading research identifies genetic determinants and biomarkers of complex lung diseases, including asthma and pulmonary fibrosis, through the use of Next-Generation sequencing technologies. 

Dr. Seibold earned his PhD from the University of California, San Francisco, and completed a post-doctoral fellowship at National Jewish Health. He has five patents and has been published more than 80 times, in some of the most prestigious peer-reviewed journals. 

Most recently, Dr. Seibold co-authored a Human Lung Cell Atlas, which has quickly become an important reference tool for researchers seeking to understand gene expression in lung disease and the roles that the more than 50 different types of lung cells play. The Atlas has been compared to the revolutionary Human Genome Project, which served as an atlas of human genes and unleashed a flood of genetic discoveries. 

Dr. Seibold is also leading the groundbreaking PRIMERO Study, to uncover root causes of asthma by studying 4,000 children in Puerto Rico, where asthma prevalence and deaths are among the highest in the world.

JP Valin

James P. (JP) Valin, MD, MHA, FACP

Executive Vice President, Chief Clinical Officer
Intermountain Health

Dr. Valin was named Intermountain Health’s Chief Clinical Officer in 2022 when the organization’s merged with SCL Health. He now leads clinical operations for 33 hospitals and 385 clinics across a 7-state region, focusing on improving equitable access to the highest quality care for patients and communities.

He is nationally recognized for advancing the value-based care model, which focuses on Intermountain’s mission of Helping People Live the Healthiest Lives Possible while ensuring affordability.

Dr. Valin previously served as Executive Vice President and Chief Clinical Officer and President of Medical Group and Provider Services at SCL Health, and served in leadership for 10 years at Banner Health. He practiced clinically for 15 years as a general internist and as a hospitalist.

He graduated from Georgetown University and New York Medical College, completing his Internal Medicine Residency at New York Presbyterian – Weil Cornell in New York City. He completed the Health Management Academy – GE Fellows Program for Physician Executives and holds a master’s in healthcare administration from the Health Management Academy/University of Providence. He is certified by the American Board of Internal Medicine and is a Fellow of the American College of Physicians.

Dr. Valin received the Clinician Experience Project’s CEO Award of Excellence and was recognized for Pandemic Heroism by the Leapfrog Group. In addition, he received Huron’s What’s Right in HealthCare® Hero Award for having a positive impact on the healthcare industry.


James N. Weinstein

Senior Vice President, Microsoft Health

Dr. Weinstein joined Microsoft Health in 2018 to lead strategy and innovation. Today, he leads global efforts in health access and health equity. Previously, he was the CEO and President of Dartmouth Health, President of the Dartmouth physician group and the inaugural Director of the Dartmouth Institute.

He is a member of the National Academy of Medicine (NAM) and served on the organization’s Board for Population Health and Public Health Practice. A recognized public health expert, he created the first value-based, population health operating model and led the national efforts in Patient Reported Outcome Measures and Health Equity for NAM. He worked with Congress during three presidential administrations and was appointed by President Barack Obama to the U.S. Veterans Administration’s Special Medical Advisory Group. 

Dr. Weinstein serves on several boards, including Intermountain Health System, a partner to National Jewish Health. Among his honors and awards, he has been named one of “The 100 Most Influential People in Healthcare” by Modern Healthcare and a top 50 “Physician Leaders to Know” by Becker’s Hospital Review.

He is a clinical professor at Northwestern Kellogg School of Management and a distinguished professor at Dartmouth Tuck School of Business. He authored the book “Unraveled: Prescriptions to Repair a Broken Health Care System” as a roadmap for many changes needed in health care. He also contributed to “The AI Revolution in Medicine: GPT-4 and Beyond,” published in March 2023.